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Abstract
Importance: Clinical signs and symptoms for COVID-19 remain the mainstay of early
diagnosis and initial management in the emergency department (ED) and inpatient set-
ting at many hospitals due to delays in obtaining results of PCR testing and limitations
in access to rapid antigen testing. The majority of many patients with COVID-19 will
present with respiratory symptoms necessitating a chest x-ray (CXR) as a routine part
of screening. An AI-based model to predict COVID-19 likelihood from CXR findings
can serve as an important and immediate adjunct to accelerate clinical decision making.
Objective: To develop a robust AI-based diagnostic model to identify CXRs with
COVID-19 compared with all non-COVID-19 CXRs.
Setting: Labeled frontal CXR images (samples of COVID-19 and non-COVID-19)
from the M Health Fairview (Minnesota, USA), Valencian Region Medical ImageBank
(Spain), MIMIC-CXR, Open-I 2013 Chest X-ray Collection, GitHub COVID-19 Image
Data Collection (International).
Main Outcome and Measure: Model performance assessed via Area under the Re-
ceiver Operating Curve (AUROC) and Area Under the Precision and Recall Curve
(AUPRC).
Results: Patients with COVID-19 had significantly higher COVID-19 Diagnostic Scores
than patients without COVID-19 on both real-time electronic health record and external
(non-publicly available) validation. The model performed well across all four methods
for model validation with AUROCs ranging between 0.7 – 0.96 and high PPV and speci-
ficity. The model performed had improved discrimination for patients with “severe” as
compared to “moderate” COVID-19 disease. The model had unrealistic performance
using publicly available databases, reflecting the inherent limitations in many previously
developed models relying on publicly available data for training and validation.
ii
Conclusions and Relevance: AI-based diagnostic tools may serve as an adjunct,
but not replacement, to support COVID-19 diagnosis which largely hinges on exposure
history, signs, and symptoms. Future research should focus on optimizing discrimination
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The coronavirus disease 2019 (COVID-19) outbreak started was first reported on De-
cember 31, 2019, when Chinese authorities described a cluster of cases of pneumonia
linked to the Huanan Seafood Wholesale Market in the Chinese city of Wuhan, Hubei
Province [5]. Shortly thereafter, the virus spread rapidly within China and across the
globe, with large sustained outbreaks on all six continents. The World Health Organi-
zation designated COVID-19 a global pandemic on March 11, 2020, and as of November
23rd 2020, there have been 59,515,380 confirmed cases and 1,402,032 deaths worldwide
[6]. The rapid and sustained transmission of the virus has overwhelmed health systems
worldwide and resulted in a shortage of critical equipment and supplies [7]. In the ab-
sence of an effective treatment, rapid identification and isolation of infected individuals
has emerged as a key tool in curtailing the pandemic [8].
The mainstay of COVID-19 diagnosis is nucleic acid testing of upper or lower res-
piratory tract swab specimens using reverse transcription polymerase chain reaction
(RT-PCR)[9]. However, due to limited RT-PCR capacity and shortages of testing sup-
plies, RT-PCR today remains a bottleneck and delay for COVID-19 diagnosis. While
many tertiary centers have acquired the capacity for in-house testing, most still need to
send their samples to external laboratories. Even when readily available, turnaround
times may exceed to 24- 48 hours, especially and possibly more in low resource set-
tings [10]. While recent rapid PCR kits providing results in as little as 5 minutes show
1
2
promise, they are still not widely available to the healthcare system at large. Diagnostic
Variability in the type of kit used, quality of sample collected, and transport limitations
can significantly influence the reliability of the test, with recent studies reporting sensi-
tivity as low as 60-71% [11]. RT-PCR samples may be obtained very early in the disease
course, before the viral load is high enough to be reliably and accurately detected, and
thus can be highly dependent on when the sample is taken. Furthermore, a patient’s
PCR result can be negative (or revert to negative) after the patient has mounted a
successful recovery from the illness, which could cause a missed diagnosis of COVID-19.
To overcome the current limitations of testing, clinicians are increasingly relying on
using more immediate clinical information to better manage patients suspected of har-
boring the infection, including first-line use of Chest computed tomography (CT) Scans
for diagnosing COVID-19 in China [12] and chest radiographs (CXR) in the United
Kingdom [10]. Previous studies have reported a high sensitivity (97-98%) for such an
approach to identify COVID-19 [13], [14]. Despite its promise of high clinical utility,
widespread use of CT scans as a means of rapidly identifying COVID-19 disease has
limitations. This approach is resource-intensive, requires additional personal protec-
tive equipment (PPE), requires transportation of potentially infectious patients to the
scanner, and is sensitive to human factors (delays in image reading and potential for
misdiagnosis)[15]. As such, the American College of Radiology and the CDC recommend
that CT should not be used for screening or as a first-line test to diagnose COVID-19
at this time [16].
The need persists for a readily available test to aid the emergency department,
urgent care, and inpatient providers in identifying a patient at high-risk for COVID-19.
Given widespread availability, low cost, and convenience, CXRs have emerged as the
frontline diagnostic imaging test when combined with clinical history and key blood
markers [10]. CXR is a safe and readily available resource in all hospitals and can
be performed at the bedside. Automated methods to screen CXRs for COVID-19 in
real-time, prioritize potential positive images for radiologist review, and deliver AI-
enabled decision support to early hospital responders may improve provider accuracy in
detecting and isolating potential COVID-19 patients, limit hospital spread of the virus,
and save critical healthcare resources. In this study, we hypothesize that an AI-model
using CXRs can accurately identify COVID-19 positive patients as well as differentiate
3
them from other pulmonary pathologies.
1.2 Objectives and Context
This study aims to develop a robust Artificial Intelligence (AI) model to help radiologists
distinguish COVID-19 positive vs. negative cases given chest x-ray images. To ensure
the model’s generalizability, data for model development and evaluation comes from
diverse sources, including private hospital data and open-source data.
Whilst medical considerations are also a vital component of this study, the purpose
of this thesis is to satisfy the Computer Science graduate degree requirement. Thus,





This chapter will discuss the background knowledge to understand the methodology
outlined in Chapter 3. First, we will discuss the basic high-level concept of deep neural
network models, followed by the current state of the art of their usage in medical image
analysis. Second, we will discuss the concept of the generative adversarial network
(GAN).
2.1 Deep Neural Networks
Over the past few years, we have witnessed tremendous advances in machine learning
using deep neural networks. Driven by the rapid increase in computational resources and
available data, these neural network methods become state of the art in fundamental
tasks in computer vision, such as image classification, recognition, and segmentation
[17], [18], [19]. As these neural network models become increasingly powerful, their
usage is becoming more popular in safety-critical domains, especially in medical image
analysis [20].
There have been extensive reviews covering the use of deep learning methods in
the medical domains. [21] covers deep neural network applications for fundamental
tasks in the medical image analysis, such as object detection, image segmentation, and
registration. [22] identifies the achievements made and the key challenges faced in this
4
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line of research, along with the promising future direction. [23] focused on Convolutional
Neural Network (CNN), the most commonly used neural network architecture for visual
perception tasks, used in medical image analysis. [24] provided a comprehensive review
of the state-of-the-art CNN techniques in this domain.
The methodology discussed in chapter 3 uses CNN architecture, on which this sub-
chapter will mainly focus on. This sub-chapter is structured as follows: the first part
serves as an introduction to the Convolutional Neural Networks architecture. The sec-
ond part outlines the common practice of using CNN in medical image analysis, namely
transfer learning. The third part presents the kinds of tasks CNNs are useful for, espe-
cially in the medical image analysis domain (e.g., image classification and segmentation).
2.1.1 Convolutional Neural Networks (CNN)
Supervised Learning
Before going in-depth to the CNN architecture, it is helpful to briefly discuss the su-
pervised learning framework, the most standard method to train CNN models. In this
framework, we are given pairs of data instances and an associated label for each in-
stance, which can be illustrated as (data instance, label) pairs. For example, in this
study, the data instances are chest x-ray images, and the labels are whether it shows
symptoms of COVID-19 (e.g., binary yes/no). Training the CNN model is finding the
parameter values as such when it receives the data instance (e.g., the chest x-ray), it
correctly assigns the corresponding label (e.g., COVID positive or negative). Finding
these parameter values requires performing iterative optimization using these labels as
a form of supervision.
Neural network models mainly operate in one of the two modes: (1) Training and (2)
Evaluation. After finding the optimum parameter values that assign correct labels to
the training data samples during the training phase, in evaluation, we stop performing
updates to these parameters. Now, given data samples never seen during training, the
network performs operations between the data sample and the learned parameters to
output its predicted label. Figure 2.1 illustrates the supervised learning framework.
6
Figure 2.1: Supervised Learning Framework [1]
CNN Architecture
CNNs are arguably the most well-known family of neural networks when it comes to
analyzing image data. They owe the popularity to the convolutional layers, which
allow the neural network to share parameters across spatially close pixels within an
image. This capability comes especially handy when it comes to extracting image fea-
tures to feed into the classification layers. The extracted features automatically capture
the encoded spatial information and relationship between image pixels, thus replacing
the need for hand-crafted features. CNN architecture typically consists of convolution
layers, pooling layers, and fully connected layers.
• Convolutional layers. Convolutional layer parameters consist of a set of learn-
able image filters, represented as 2-dimensional arrays. After receiving an input
image, we slide each filter across the width and height of the image and compute
the dot products between filter parameters and image pixel values at any position
(i.e., the convolution operation). The output of this process is called the activa-
tion maps. Equation 2.1 shows the convolution operation for an image I of size
(m× n) and filter K.
S(i, j) = (I ∗K)(i, j) = ΣmΣnI(m,n)K(i−m, j − n) (2.1)
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The activation maps are then passed through an element-wise activation function
to introduce non-linearity in the CNN weights. The most widely used activation
function is the rectified linear unit (ReLU) [25]. The learned filter parameters at
earlier layers will extract some type of visual features such as the object’s edge or
colors, and the filters at the deeper level of the network will learn to extract more
high-level patterns such as the shape of the objects.
• Pooling layers. It is a common practice to insert Pooling layers in between
successive Convolution layers in a CNN. This layer reduces the spatial size of
image representation as we go deeper in the network, reducing the number of
parameters and computation load. It takes the output of the convolution layer
and performs pooling through a similar filter sliding operation. However, here,
the pooling layer takes the maximum of the pixels within the area covered by the
filters. For example, using filters of size 2 × 2 would be taking the largest of 4
numbers in the 2× 2 region. There are other less-common types of pooling, such
as average pooling and global pooling.
• Fully Connected layers. After getting the 2-dimensional image representation
through a series of successive convolution and pooling operations, this represen-
tation is then flattened into a 1-dimensional vector to be processed in the fully
connected layer and get the predicted label. The structure of this layer
Figure 2.2: Fully Connected Layer
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is a network of interconnected neurons [26] stacked in a layered fashion to form
Artificial Neural network [27] as shown in Figure 2.2. The circles in Figure 2.2
illustrates neurons, and the interconnected lines represents the weights (parame-
ters). The output of each neuron with a set of weight w and bias b, given an input
vector x is illustrated in equation 2.2.
y = wTx + b (2.2)
The latest layer of neurons represents the classification labels. In the example,
data samples that are assigned to ”Covid +” label will have higher values in that
neuron, and lower value in ”Covid -” neuron.
Figure 2.3 shows an example of the full CNN operations pipeline for digit classification
task.
Figure 2.3: CNN Network Example
Transfer Learning
One of the biggest bottlenecks in training a deep neural network model is the need for
an enormous amount of data to find the optimum parameters. One popular practice to
tackle this is transfer learning - a two-step process comprised of a pretraining step
and a finetuning step.
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More specifically, we start from a neural network with randomly initialized parame-
ters and train it on a generic task (e.g., classifying natural images)- the pretraining step.
In computer vision applications, the most common pretraining step is using Imagenet
[28], a large dataset of natural images and their labels. The pretraining step allows
the network to have parameter values suitable for the generic tasks, allowing it to learn
useful high-level features (e.g., recognizing object edges or colors). The finetuning step
trains the neural network further on the true target task (e.g., classifying whether a
chest x-ray is associated with a particular disease).
Previously in section 2.1.1, we have made references to the distinction between the
types of features learned on the first and last layers of CNNs - first layer filters learn
to extract low-level features such as object edge and colors, while deeper layer learns
higher-level features like objects shape. The common practice of transfer learning follows
this understanding. Usually, the finetuning step only modifies the parameters in the
last few layers, freezing the initial layers’ parameter. Intuitively, we reuse the layers
that learn low level features from the generic task and further train the last layers to
learn different high level features.
Previous works on building CNN models for disease recognition have commonly used
publicly available pretrained models (e.g.,AlexNet [29], DenseNet [30], ResNet [31], VG-
GNet [32], GoogleNet [33]) and finetune using open source medical image datasets (e.g.,
CheXpert [34] and MIMIC [35], the two popular chest-xray datasets with disease labels),
or internal hospital data. [36] found improved performance on Computer-Aided Detec-
tion task with pretraining using ImageNet despite the disparity with the target medical
dataset. [37] experimented on disease detection tasks using different medical imaging
modalities and found that the transfer learning approach consistently performs better
than training the network from scratch. [38] evaluated the performance of different
pretrained CNNs on chest X-ray disease classification task.
2.1.2 CNN Applications in Medical Image Analysis
This part discusses two of the most popular applications of CNN in medical image anal-
ysis: Image Classification and Semantic Segmentation, which are the main components
of the methodology in Chapter 3.
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Image Classification
Classification is arguably the simplest and most widely used CNN application. Given
images, classification models output a class label - one of the mutually exclusive pre-
defined set of labels seen during model training. For example, in this study, we train
the CNN using a dataset of (chest x-ray, COVID-19 label) pairs. In evaluation, given
an unseen chest x-ray image, the CNN model outputs the predicted binary COVID-19
disease label.
The architecture characteristic for this task lies in the last fully connected (FC)
layer, where each neuron represents one class, and their outputs are the likelihood of
the data point belonging to that particular class. We can use a single neuron for binary
classification, where the labels predictions will be based on whether the likelihood value
is closer to zero or one.
A substantial body of work relevant to this study has looked at the uses of classi-
fication models in medical domains. Specifically, using CNN models to predict disease
labels. [39], [40], and [41] are especially relevant as they build CNN models to classify
diseases by looking into radiology images (i.e. 2-dimensional x-rays and 3-dimensional
CT scans). A comprehensive survey about this line of work across various medical
imaging modalities can be found in [42].
As these models become increasingly prevalent in actual clinical practice, [43] poses
an important point that the models should serve as a second reader in clinical decision
making, helping human readers produce pathology reports, but cannot be a permanent
replacement.
Semantic Segmentation
Segmentation dives into the lowest possible of detail. Instead of classifying the image,
we classify each pixel into higher-level groups they belong to. Because it categorizes
every pixel, the output of the segmentation model is not a class label but a full image.
For instance, in figure 2.4, the output of segmentation model is an image of three pixel
values, each belongs to one of the ”Person”, ”Bicycle” or ”Background” class. Some
popular open-source segmentation models are U-net [44] and SegNet [45].
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Figure 2.4: Semantic segmentation illustration
In medical image analysis, segmentation is used to extract more meaningful infor-
mation in an image by dividing the original image into either background or meaningful
objects. For instance, suppose we are given a chest x-ray, we would like to determine
if a pixel is part of the lung, background, or device implants. Segmentation is often
used as a preprocessing step before classification. Removing background area or device
implants from the image before feeding it to the classification model can reduce the
possible search area. Thus aiding the model in learning which feature is important for
the classification task.
2.2 Generative Adversarial Network
This section discusses Generative Adversarial Network (GAN): (1) What is GAN, (2)
How it works, (3) The type of GAN used in this study (i.e., Conditional GAN).
2.2.1 What is GAN
Generative Adversarial Network was first introduced in 2014 [46]. It is a member of the
generative model family - given a training set of samples drawn from a data distribution
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pdata, the goal of generative models is to represent an estimate distribution pmodel of the
original distribution pdata. More concretely, the expected result of training a generative
model is to generate new data instances that resemble the training set (i.e., pmodel as
close as possible to pdata).
The classification models discussed in the preceding section are a family of discrim-
inative models. Unlike discriminative models that tell us how likely a class label is to
be assigned to a data instance (i.e., P (Y |X)), generative models capture the underlying
data distribution (i.e., P (X) or P (X,Y )).
Figure 2.5: Generative model vs Discriminative model [2]
Figure 2.5 illustrates the distinction between the two model families. Discriminative
models find a plane in the data space that separates the different classes. Finding this
plane alone is sufficient to distinguish the classes of data samples without having to
estimate where these samples lie in the data space. In contrast, Generative models
estimates the location of these samples in the data space in order to produce new data
samples that resemble the training data.
2.2.2 How GAN Works
Figure 2.6 illustrates the structure of GANs. It consists of two neural networks (1)
Generator (G), and (2) Discriminator (D). The two exist within one GAN structure
with competing aims. The Generator ’s objective is to produce fake data instances such
as they are not distinguishable from the real training instances. On the other hand,
13
Figure 2.6: GAN Structure [3]
given a data instance, the discriminator aims to detect whether it comes from the real
distribution (i.e., training data), or the ’fake’ distribution modeled by the Generator.
Discriminator Network
Discriminator network (D) in GAN is simply a classification model. Its aim is to dis-
tinguish between the real training data samples from the fake samples produced by
generator G. As shown in Figure 2.6, D network’s inputs are the real training samples,
and the fake samples produced by G. D’s output is its prediction of whether the input
image is ”real” or ”fake”.
Generator Network
Given random noise z, Generator network G learns to generate fake data samples such
that the discriminator D cannot distinguish them from the real training samples. During
training, the D network’s output is also incorporated into the generator (illustrated by
the bottom dashed line in Figure 2.6). This serves as some sort of feedback - at the
current training stage, how well can G’s outputs fool D? In other words, how close
are the generated ”fake” outputs to the real training samples. Hence, as the training
progresses, G will learn how to fool D better.
14
2.2.3 Conditional GAN
GAN enables us to generate data samples that resemble those in the training set. How-
ever, we cannot control data from which class the GAN network produces. Conditional
GANs (CGANs) [47] lets us specify the label for each generated instance.
Figure 2.7: Conditional GAN architecture [4]
Figure 2.7 illustrates CGAN architecture. The generator ’s input now consists of a
random vector z and label information Y . Similarly, The discriminator has an addi-




This chapter details the experimental setups and methodology. First, the data acqui-
sition sub-part will describe all internal and external data sources. Second, the image
processing pipeline will be discussed. Third, the model development methodology will
be outlined.
3.1 Data Acquisition
The model was trained and validated using two types of data sources: (1) M Health
Fairview dataset, and (2) collection of publicly available datasets.
3.1.1 M Health Fairview Datasets
All CXRs obtained at M Health Fairview, Minnesota, USA (12 hospitals, 60 clinics)
were considered eligible for inclusion. Images from patients with age lass than 18 years
old were excluded in training or validation.
M Health Fairview Model Development (Training) Dataset
We obtained 2,220 CXRs from patients with PCR confirmed COVID-19 (taken either 2
weeks prior COVID-19 diagnosis or during a COVID-19 associated hospitalization) and
36,288 non-COVID-19 CXRs from M Health Fairview for model training and optimiza-
tion. All the COVID-19 positive case CXRs were obtained between March 2nd 2020, to
June 30th, 2020, and the negative controls were obtained between October 25th, 2016
15
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to March 3rd, 2020. All CXRs were taken in Minnesota, U.S.A at an M Health Fairview
clinic or hospital.
The mean age in the positive controls was 59.8 (standard deviation, 16.2) years old
and the mean age in the negative controls was 58.6 (standard deviation, 18.6) years
old. 48.5% of CXRs in the positive controls were from males and 49.4% of CXRs in the
negative controls were from females.
M Health Fairview Prospective Validation Dataset
Prospective validation included all CXRs within the M Health Fairview system obtained
between July 1, 2020 – July 30, 2020. To account for prevalence, varying ratios of case
imbalance were evaluated against using a ratio of 1:1 (50% positive:negative) to 1:20
(4.8%). During this prospective time period there were CXRs from 5,228 patients that
were negative for COVID-19 and 1,777 patients that were confirmed PCR positive for
COVID-19 for a prevalence rate of 25.4%). The mean age in the positive controls was
61.6 (standard deviation, 16.2) years old and the mean age in the negative controls was
57.5 (standard deviation, 18.5) years old. 68.6% of CXRs in the positive controls were
from males and 31.4% of CXRs in the negative controls were from males.
3.1.2 Publicaly Available Datasets
Publicly Available COVID-19 Datasets
COVID-19 positive cases were collected from two open source COVID-19 databases,
namely BIMCV COVID-19+ [48] and COVID Chest X-ray Github [49]. BIMCV COVID+
contains 2261 CXRs (after taking out CT images) and were collected from 11 hospitals
from the Valencian Region, Spain, and the positive cases were dated between Febru-
ary 26th and April 18th, 2020. We included all frontal X-Rays (Images with “view”
column attribute values: ”PA” or ”AP” or ”AP Supine” or ”AP semi erect” in the
Github metadata) with ”COVID-19” or ”COVID-19, ARDS” or ”SARS” labels from
the COVID Chest X-Ray Github. In total, we have 504 images from this dataset.
Publicly Available non-COVID-19 Datasets
For COVID-19 negative cases, we collected cases and frontal images combined from: (1)
2011 – 2016 MIMIC-CXR [50] (random sample of 23,611 images); and (2) Open-I 2013
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Indiana University (IU) Chest X-Ray Collection [51] (random sample of 3,814 images).
Images in MIMIC-CXR and Open-I sets are dated prior to December 2019 resulting
in 27,424 images of patients with no particular medical status except the absence of
COVID-19.
Patient demographic information in publicly available datasets was not available as
it was removed by the originating institutions to facilitate patient de-identification.
3.2 Image Pre-processing
All the original X-rays were in the DICOM format. We worked only with frontal X-rays
(with DICOM position attribute “PA” or “AP”). All X-rays were converted into PNG
images. All images were resized and zero-padded. First, the image ratio was locked so
that the larger dimension of the height and the width was resized to 1024. Next, zero-
padding was then performed to the other dimension, so that the resulting size becomes




Where I denotes image pixels and Pmax and Pmin denote the maximum and minimum
values of the image. Image pre-processing was done using the Python scikit-image
package [52].
3.3 Model Development (Training)
For model development, 38,508 (2,220 positives and 36,288 negatives) M Health Fairview
CXR were used for training. Model training was supplemented to maximize model
generalizability using publically available (9,592 total with a positive:negative ratio of
1:16) images of COVID-19 positive and negative patients. In the training set, 444
positives and 7,257 negatives were held out only for tuning the hyperparameters of the
deep learning models and rest were used to train the models.
Our main model pipeline consisted of: (1) lung segmentation, (2) outlier detection,
and (3) feature extraction/classification part. Figure 3.1 illustrates the complete model
pipeline.
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Figure 3.1: Overview of COVID-19 Diagnostic Model Pipeline
3.3.1 Lung Segmentation
We performed lung segmentation to focus the learning around the lung area, where the
COVID-19 radiomic features are located. For this, the U-net model [44] that had been
popular for biomedical image segmentation was adopted. The segmentation model was
trained using three publicly available lung segmentation datasets: Montgomery [53],
HIN [54], and JSRT [55]. The three datasets provided manual segmentation masks (i.e.,
segmentation labels).
The segmentation was not perfect. The resulting output mask often contains only
part of the lung area and tend to be scattered over the whole lung area. To minimize
the possibility of missing COVID-19 related radiomic features, we cropped out the
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smallest square area that enclosed the predicted mask. All such square lung areas were
subsequently resized into 512× 512, whether they were larger or smaller.
3.3.2 Outlier Detection
Practical X-rays have large variations and some of the extreme cases, e.g., caused by
high/low exposure, skewed positions, or wrong position attributes. These variations
can substantially contaminate the model training or the prediction process. To avoid
overburdening the model, we chose to isolate these infrequent extreme cases for human
screening.
We implemented two sequential procedures for this. First, before lung segmentation,
we trained a Conditional Generative Adversarial Network (CGAN) [47] on the training
CXRs to separate potential outliers. The class labels were fed into the conditional
GAN as the “conditional” information. After training, any samples that were assigned
scores lower than 0.1 by the discriminator with corresponding both positive and negative
“conditional” information were declared as outliers. After the lung segmentation, we
calculated the ratio of the area of the predicted lung mask and the area of the whole
X-ray image for the remaining samples. Any CXR with a ratio below 0.1 or above
0.9 would be removed as outliers. The two procedures rejected about 10% of all input
images, most of which were visually confirmed as challenging cases.
3.3.3 Feature Extraction and Classification
Previously in section 2, we have discussed two main bottlenecks in deep neural network
training: (1) the need of huge amount of data, and (2) slow training time. In this
study, reduce the training time by performing transfer learning (refer to chapter 2.1.1).
We took a pre-trained DenseNet-121 [30], and further train the model using our CXR
datasets to fine-tune it to recognize COVID-19. The difference between the prediction
and the target (1 for positive and 0 for negative) was measured using the standard cross-
entropy loss. The network was implemented using the deep learning package PyTorch
1.5.0 [56].
The positive cases and negative controls ratio in our dataset was imbalanced, re-
flecting the intrinsically biased distribution of COVID-19 cases in the population. To
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counter the adverse effects of the imbalance on learning, we set our training objective




Two methods of validation were performed. First, model performance was evaluated
prospectively using data retrospectively collected during the month of July, 2020 within
the M Health Fairview System. Second, model performance was evaluated using pub-
lically available COVID-19 and non-COVID-19 imaging databanks. The COVID-19
Diagnostic Score from the model ranged from 0 to 1, indicating the likelihood of COVID-
19.
To represent the performance of the model on different ratios, we calculated all
the metrics on 1:1, 1:2, 1:5, 1:12, and 1:20 respectively for M Health Fairview and
publically-available data validations. These ratios were obtained by subsampling the
remaining validation data and all numbers reported were the average over 10 random
repetitions. 10 random sub-samples were selected from this pool of images to construct
mean estimates of AUROC (area under the receiver operating characteristic curve)
and AUPRC (area under the precision recall curve). Specificity, sensitivity, positive





4.2.1 Prospective Validation using M Health Fairview CXR
This model was first evaluated via prospective validation using M Health Fairview im-
ages collected between July 1 – July 30, 2020. 7,005 CXRs were obtained in adults
age 18 and older during this time period. 1777 images were from patients with PCR
confirmed COVID-19 positive for a 25.4% prevalence. The mean AUROC and AUPRC







Table 4.1: Prospective Validation for July 2020 using M Health Fairview CXRs
Distribution of COVID-19 Diagnostic Scores for both positive and negative cases
during the month of July 2020 are provided in Figure 4.1.
Using the following thresholds for unlikely (score < 0.04), indeterminate (score 0.04
– 0.4, 22.1% of images) and likely (score > 0.4) the following Specificity, sensitivity,
PPV, and NPV are obtained (see table 4.2). Around 20% of the test images predictions
were discarded from outlier detection module and indeterminate score combined.
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Figure 4.1: Distribution of COVID-19 Diagnostic Scores (X-axis) for patients with PCR
confirmed positive COVID-19 (purple bars) and non-COVID-19 patients (green bars)
during the month of July 2020.
Ratio Specificity Sensitivity PPV NPV
1 0.934 0.659 0.909 0.733
2 0.935 0.659 0.835 0.846
5 0.934 0.664 0.668 0.933
12 0.934 0.649 0.449 0.970
20 0.934 0.677 0.338 0.983
Table 4.2: Prospective Validation for July 2020 using M Health Fairview CXRs for
0.04 – 0.4 thresholds
To better understand these results we performed separated evaluation on images
from patients with “severe” disease (patients that required ICU admission) and “mod-








Table 4.3: Prospective Validation for July 2020 using M Health Fairview CXRs for







Table 4.4: Prospective Validation for July 2020 using M Health Fairview CXRs for
patients with “moderate” COVID-19 disease
4.2.2 Validation using publicly available COVID-19 CXRs
Similarly, the model was validated using a sample of publicly available COVID-19 CXRs.
Table 4.5 summarizes the quantitative performance, and figure 4.2 shows the distribu-








Table 4.5: External Validation using publicly available COVID-19 CXRs
Figure 4.2: Distribution of COVID-19 Diagnostic Scores (X-axis) for patients with
COVID-19 (purple bars) and non-COVID-19 patients (green bars) from publically avail-
able datasets, prevalence
To better understand these results we evaluated individual performance from the















Table 4.7: Publicly Available (BIMCV) COVID-19 CXR validation
Chapter 5
Discussion and Conclusion
5.1 Summary of Key Finding
M Health Fairview validation results in AUROC of roughly 0.8 across all ratios and
AUPRC range of 0.4 - 0.84. Evaluation on the publicly available datasets yields AUROC
of roughly 0.96 across all ratios and 0.92 - 0.97 AUPRC.
Furthermore, more fine-grained evaluation on ”severe” vs. ”moderate” cases was
performed on the M Health Fairview data, yielding non-trivial differences on the two
cases’ AUROC and AUPRC. ”severe” cases evaluation yields 0.83 AUROC and 0.48
- 0.87 AUPRC, while ”moderate” cases has AUROC of roughly 0.7 and 0.218 - 0.74
AUPRC. In contrast, individual evaluations on each public dataset source yield similar
results across all sources (>0.9 AUROC and AUPRC).
5.2 Results Interpretation
5.2.1 M Health Fairview Evaluation Results
Model performance on the M Health Fairview dataset has > 0.93 specificity scores across
all ratios and sensitivity scores between 0.65 - 0.67. This result suggests disparity in the
model’s capacity to identify negative cases vs. identifying the positives. This contrast is
also apparent in figure 4.1. Negative prediction scores are concentrated at the leftmost
regions, while some positive predictions are wrongly assigned low likelihood values (blue
colored bars in leftmost regions).
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We attempted to explain this disparity by looking at the more fine-grained experi-
ments on the individual ”severe” and ”moderate” cases. The performance on ”severe”
cases outperforms the performance on ”moderate” cases by 0.12 - 0.13 AUROC and
AUPRC scores margins. This result implies that mixing the ”severe” and ”moderate”
cases might contribute to the model’s performance disparity. More severe COVID-19
cases show more visible characteristics on CXRs; hence, it is easier to distinguish from
the negative cases.
5.2.2 Public Dataset Evaluation Results
The model consistently performs with > 0.9 AUROC and AUPRC on the combination
of public datasets and the individual ones. This high performance is also implied by
figure 4.2, showing only a small portion of the positive samples wrongly classified (blue
bars in left regions) and almost all the negative predictions concentrated on the leftmost
area.
While it is tempting to imply the model has a high generalization capacity, more
rigorous analysis is needed to inspect this result. Machine learning models tend to resort
to trivial information extracted from images [57], [58]. As the public evaluation data
comes from multiple sources with different image characteristics (i.e., image contrast,
organs size or device implants), the model might take advantage of this irrelevant in-
formation instead of making predictions based useful COVID-19 features on the public
dataset.
5.3 Results Implications
The result shows promise that the performance of the model on the M Health Fairview
data is adequate for the established role of CXR as a frontline tool for screening and
triage. If properly incorporated as an AI-enabled clinical decision support into the
workflow of current diagnostic modalities, the model has the potential to considerably
improve the speed and reliability of current screening procedures. However, the gener-
alization capacity of this model still need further inspection and improvement. Future




This study is not without limitations. First, the number of our positive controls is
relatively small. Second, our negative controls were not selected from a target population
of suspected COVID-19 patients. Third, CXR findings for COVID-19 are nonspecific
and overlap with a number of other infectious and non-infectious etiologies, which could
complicate interpretation. Fourth, this model has not been tested in a clinical setting,
which also introduces the additional uncertainty of not having a gold standard test(s)
for true positive and true negative in cohort analysis. As such, it is difficult to say
how well the model will perform in the real world and across different settings. Lastly,
these models were trained and validated on fixed data. The models will evolve as
new data arrive. It is possible to modify the models to make them gradually improve
over time, leveraging advances in online machine learning. Finally, the integration of
radiometric characteristics of COVID-19 positive patients will further improve models.
Future directions will implement and prospectively evaluate these diagnostic models.
5.5 Conclusion
In conclusion, we provide an accurate and reliable model capable of differentiating
between CXRs of patients with COVID-19 from non-COVID-19 CXRs. Delivery via an
AI-enabled clinical decision support system for treating clinicians and radiologists may
result in faster isolation, confirmatory PCR-based testing, and treatment. This could
potentially decrease hospital contamination and provide better quality of care.
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